PUBLIC CONTRACT · 2017
Infliximab 100 mg (biossimilar) pó conc sol inj fr IV
- Contract value
- €57,461.60
- Signed on
- 20 June 2017
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3473042PUBLISHED SUBJECT
INFLIXIMAB 100 MG (BIOSSIMILAR) PÓ CONC SOL INJ FR IV - Ajuste Directo No 11151917
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Almada
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- PHARMAKERN PORTUGAL · Tax ID 507002571
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €57,461.60
- Procedure base price
- €57,461.60
- Total effective price
- Not reported on Portal BASE
- Publication date
- 29 June 2017
- Award date
- 13 June 2017
- Signing date
- 20 June 2017
- Performance period
- 30 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- CP 2015/6 - Acordo quadro para o fornecimento de Medicamentos do Foro Oncológico
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2816636
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.